Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aglaroxin C and derivatives as HCV entry inhibitors

Aglaroxin C and derivatives as HCV entry inhibitors

US Patent 10085988 · Granted Oct 2, 2018

Estimated economic value: $16,088,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds as immunomodulators2025
Heteroaryl amide compounds as sting activators2024
Water heater, and scale detection system and method2024
Heterocyclic compounds as immunomodulators2024
Fungal modulators2023
Tricyclic heterocyclic compounds as sting activators2023
Heterocyclic compounds as immunomodulators2022
Method and apparatus for response using voice matching user category2022
Tricyclic amine compounds as CDK2 inhibitors2022
Compositions and methods for inhibiting viral infection2022
Compositions and methods for inhibiting viral infection2022
Compositions and methods for inhibiting viral infection2022